T. Rowe Price Investment Management, Inc. 13D and 13G filings for Immunome, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 10:06 am Purchase | 2026-03-31 | 13G | IMMUNOME INC IMNM | T. Rowe Price Investment Management, Inc. | 16,364,011 14.500% | 5,719,337 (+53.73%) | Filing |
| 2025-11-07 1:02 pm Purchase | 2025-10-31 | 13G | IMMUNOME INC IMNM | T. Rowe Price Investment Management, Inc. | 10,644,674 12.200% | 4,882,661 (+84.74%) | Filing |
| 2024-11-14 1:28 pm Purchase | 2024-09-30 | 13G | IMMUNOME INC IMNM | T. Rowe Price Investment Management, Inc. | 5,762,013 9.600% | 5,762,013 (New Position) | Filing |